COVID-19: Perspectives on the Regional Impact in Brazil — Edition 3 Presentations June 30, 2020 Maurício França Rafael Freixo
Related Practice Healthcare Services Much is still unknown or uncertain about COVID-19. In particular, data accuracy in Brazil is low due to the limited number of tests and the unavailability of granular public data. 01262022160122
Published Articles Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies February 27, 2024
Executive Insights Healthcare Services Navigating Asia’s Regulatory Mosaic: Achieving Excellence in Generative AI for Healthcare January 26, 2024
Executive Insights Medical Equipment Decoding Femtech Consumers: Defining Needs and Segmentation in Women’s Health January 10, 2024
Executive Insights Healthcare Services Healthcare Providers and the Data Gold Rush: How to Get Your Share September 21, 2023
Podcast Life Sciences & Pharma Access, Efficacy and Collaboration: Unlocking the Potential of Gene Therapies September 13, 2023